David Koschut

1PUBLICATIONS
4CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 28, 2020
RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia.

David Koschut, Debleena Ray, Zhenhua Li

Pageof 1

Frequent Collaborators

1 joint publications

Debleena Ray

1 joint publications

Ivan Alić

1 joint publications

Hany Ariffin

1 joint publications

Dean Nižetić